1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Could Australia become global cannabis leader?

  1. Docta
    marijuana-tree-122308-lg.jpg Australia could be a global leader in medicinal cannabis if proposed laws pass, a pharmaceutical firm says. The federal government has introduced draft laws to parliament allowing the cultivation and supply of marijuana for medicinal or scientific purposes.

    ASX-listed MGC Pharmaceuticals says that apart from the obvious health benefits for patients suffering chronic pain, the laws could create a lucrative new export industry.

    "A medical cannabis scheme also presents an opportunity to establish a booming domestic industry and the potential in the future for a significant export industry," the company said in a statement.

    "It would also enable Australia to become a global leader in the cultivation and supply of medical cannabis." MGC managing director Nativ Segev said his company had experience growing and supplying medical cannabis in Israel and Europe, and is optimistic about potential investment opportunities in an Australian market.

    "This legislation indicates that the government has recognised the potential and is starting to take the industry and its benefits for all Australians seriously," he said.

    Meanwhile, fellow pharmaceutical firm Medlab Clinical said the proposed laws could reduce clinical trial times for its pain treatment mouth-spray.

    The ASX-listed pharmaceutical firm, has been developing a marijuana-based pain treatment mouth spray, NanoCelle, since July 2015.

    Medlab chief executive Sean Hall said, if passed, the laws could reduce clinical trial times and speed up the product's launch.

    - AAP
    © Copyright 2016, NZME. Publishing Limited
    Image credit drugs-forum



To make a comment simply sign up and become a member!